What’s the recommended MMR timing after Cosentyx (secukinumab)?
Cosentyx (secukinumab) is a biologic that suppresses part of the immune system, so guidance generally avoids giving live vaccines like MMR close to treatment. The advised approach is to delay MMR until after the immune effect of Cosentyx has settled, which typically means waiting through the dosing interval and longer if your clinician recommends it.
However, the exact delay is not stated in the information provided here. To give you the correct interval for your situation, I’d need either:
- the dosing schedule you’re on (e.g., every 2 weeks vs. every 4 weeks), and
- where you’re getting guidance from (prescribing label, country-specific immunization guidance, or your rheumatologist/dermatologist’s instructions).
Why timing matters: MMR is a live vaccine
MMR contains live attenuated viruses. With immunosuppressive therapies such as anti–IL-17 drugs, clinicians typically recommend spacing live vaccines away from dosing to reduce the risk that the vaccine could cause infection or fail to generate an adequate immune response.
What to do if you already had MMR (or missed it)
If you already received MMR while on Cosentyx, contact your prescribing clinician for personalized advice and documentation of the date(s) so they can determine whether any additional monitoring is needed.
Quick next questions to confirm the correct delay
If you reply with:
1) your Cosentyx maintenance dosing frequency (every 2 weeks, every 4 weeks, or other), and
2) whether you’re asking about the first MMR dose or a booster,
I can help you translate that into the specific “delay from last dose” timing your local guidance usually uses.
Sources: None provided in the prompt.